BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36490353)

  • 1. A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.
    Chen S; Yu Y; Yuan Y; Chen X; Zhou F; Li Y; Wang P; Jiang X; Tian S; Ren W
    Aging (Albany NY); 2022 Dec; 14(24):9924-9941. PubMed ID: 36490353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel long noncoding RNA (lncRNA), LINC02657(LASTR), is a prognostic biomarker associated with immune infiltrates of lung adenocarcinoma based on unsupervised cluster analysis.
    Kong F; Yang X; Lu Z; Liu Z; Yang Y; Wang Z
    PeerJ; 2023; 11():e16167. PubMed ID: 38047034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma.
    Wang H; Shi Y; Xu X; Xu S; Shi Y; Chen W; Wang K
    Ann Med; 2023; 55(2):2279754. PubMed ID: 37980632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma.
    Huang X; Zhou H; Yang X; Shi W; Hu L; Wang J; Zhang F; Shao F; Zhang M; Jiang F; Wang Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24777. PubMed ID: 36426920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
    Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Prognostic Long Non-coding RNAs in Lung Adenocarcinoma Using WGCNA Analysis.
    Zhao C; Xu H; Liu C
    Biochem Genet; 2024 Feb; 62(1):264-280. PubMed ID: 37326895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
    Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
    Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 12. Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326.
    Zhang W; Cao C; Shen J; Shan S; Tong Y; Cai H; Han Z; Chai H
    Bioengineered; 2022 Jun; 13(6):14472-14488. PubMed ID: 36694453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
    Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
    Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
    Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F
    Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma.
    Ye W; Huang Y; Li X
    Medicine (Baltimore); 2022 Oct; 101(40):e30446. PubMed ID: 36221373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
    Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L
    Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.